The Europe hormone replacement therapy market is estimated to project a CAGR of 7.57% during the forecast period, 2021-2028. The surging hormonal disorders in women are a significant driver of market growth.

EUROPE HORMONE REPLACEMENT THERAPY MARKET FORECAST 2021-2028

Europe Hormone Replacement Therapy Market by Therapy Type (Estrogen Hormone Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Hormone Replacement Therapy, Human Growth Hormone Replacement Therapy, Progestogen Hormone Replacement Therapy) Market by Indication (Menopause, Male Hypogonadism, Growth Hormone Deficiency, Hypothyroidism, Other Indications) Market by Route of Administration (Oral, Parenteral, Transdermal, Other Route of Administrations) by Geography.

Request free sample

The Europe hormone replacement therapy market is estimated to project a CAGR of 7.57% during the forecast period, 2021-2028. The surging hormonal disorders in women are a significant driver of market growth.europe-hormone-replacement-therapy-market

To learn more about this report, request a free sample copy

The Europe hormone replacement therapy market growth assessment includes the analysis of France, Germany, the United Kingdom, Poland, Italy, Russia, Belgium, and Rest of Europe. One of the main growth drivers in the UK is the launch of new drug initiatives by key players. The National Institute for Health and Care Excellence (NICE) majorly recommends growth hormone replacement therapy for children with inadequate growth. In Italy, according to a 2021 article, a study found that HRT use in women is uncommon. Also, the national pharmaceutical agency of the country provides free hormone replacement treatment, thereby influencing market growth.

In Poland, the market growth is attributed to increasing demand for hormone replacement and a shift to non-hormonal therapies. The oldest hormone in clinical use is testosterone. Moreover, the increasing post-menopausal conditions in women and dwarfism are raising the demand for hormone replacement. In Russia, the increasing usage of HRT among transgender people and the launch of production faculties for hormonal drugs are projected to facilitate market growth.

Bayer AG is a German pharmaceutical and chemical company with businesses in veterinary pharmaceuticals, biotechnology products, agricultural chemicals, human pharmaceuticals, and human healthcare products. It is an innovative company specializing in general and specialty medicines, with a strong distribution network and research & department capabilities. It is headquartered in Leverkusen, Germany.

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • PREVAILING AWARENESS ABOUT POST-MENOPAUSAL ISSUES AMONG WOMEN
        • INCIDENCE OF HORMONAL DISORDERS
        • PRODUCT LAUNCHES BY MAJOR PLAYERS
      • KEY RESTRAINTS
        • ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY
        • HIGH COST OF TREATMENT
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
    2. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    3. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    4. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS
    5. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • THE UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES
      • COMPANY PROFILES
        • ABBOTT LABORATORIES
        • AMGEN
        • ANI PHARMACEUTICALS
        • BAYER AG
        • ELI LILLY & COMPANY
        • GENENTECH INC
        • IPSEN
        • MERCK KGAA
        • NOVARTIS AG
        • NOVEN PHARMACEUTICALS INC
        • NOVO NORDISK A/S
        • PFIZER INC
        • VIATRIS INC (MYLAN NV)

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – HORMONE REPLACEMENT THERAPY

    TABLE 2: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: LEADING PLAYERS OPERATING IN EUROPE HORMONE REPLACEMENT THERAPY MARKET

    TABLE 11: LIST OF MERGERS & ACQUISITIONS

    TABLE 12: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 13: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 14: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: KEY MARKET TRENDS

    FIGURE 2: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 3: OPPORTUNITY MATRIX

    FIGURE 4: VENDOR LANDSCAPE

    FIGURE 5: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, IN 2020

    FIGURE 6: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 7: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 10: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY INDICATION, IN 2020

    FIGURE 12: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

    FIGURE 13: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

    FIGURE 16: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, IN 2020

    FIGURE 18: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

    FIGURE 21: EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTE OF ADMINISTRATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE HORMONE REPLACEMENT THERAPY MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 23: GERMANY HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 24: FRANCE HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 25: UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 26: ITALY HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 27: RUSSIA HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 28: BELGIUM HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 29: POLAND HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 30: REST OF EUROPE HORMONE REPLACEMENT THERAPY MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • THE UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY THERAPY TYPE
      • ESTROGEN HORMONE REPLACEMENT THERAPY
      • THYROID HORMONE REPLACEMENT THERAPY
      • TESTOSTERONE HORMONE REPLACEMENT THERAPY
      • HUMAN GROWTH HORMONE REPLACEMENT THERAPY
      • PROGESTOGEN HORMONE REPLACEMENT THERAPY
    2. MARKET BY INDICATION
      • MENOPAUSE
      • MALE HYPOGONADISM
      • GROWTH HORMONE DEFICIENCY
      • HYPOTHYROIDISM
      • OTHER INDICATIONS
    3. MARKET BY ROUTE OF ADMINISTRATION
      • ORAL
      • PARENTERAL
      • TRANSDERMAL
      • OTHER ROUTE OF ADMINISTRATIONS

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type